GDRX logo

GoodRx Holdings (GDRX)

Profile

Full Name

GoodRx Holdings, Inc.

Ticker Symbol

GDRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Health Information Services

Country

United States

IPO

September 23, 2020

Indexes

Not included

Website

http://www.goodrx.com

Employees

738

Key Details

Price

$4.49(+0.79%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$792.32M(+5.61% YoY)

Annual EPS

$0.04(+300.00% YoY)

PE ratio

94.62

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$4.49
GDRX price is $4.49

30-Day Relative Volume

0.37
GDRX 30-day relative volume is 0.37

Price Performance

Price Most recent change

+0.79%
GDRX price was up +0.79% on Apr 17, 2025

Price YTD change

-3.55%
GDRX price is down -3.55% since January 1st

Price 1-year change

-31%
GDRX price is down -31% year-on-year

Price 3-year change

-75.89%
GDRX price is down -75.89% over the past 3 years

Price Range

Price All-time high

$64.22
GDRX price is currently -93.02% below its historical high of $64.22

Price 3-year low

$3.82
GDRX price is currently +17.41% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$1.72B
GDRX market capitalization is $1.72 billion

Market cap 3-year change

-76.65%
GDRX market capitalization is down -76.65% over the past 3 years

Market cap All-time high

$22.32B
GDRX market capitalization is currently -92.29% below its historical high of $22.32 billion

Market cap sector rank

81.99%
GDRX market capitalization is higher than 81.99% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+2.3%
GDRX shares outstanding is up +2.3% year-on-year

Shares Outstanding 3-Year Change

-3.16%
GDRX shares outstanding is down -3.16% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.01
GDRX beta is 1.01

200-day SMA

$5.92
GDRX price is currently -24.29% below its 200-day simple moving average

50-day SMA

$4.64
GDRX price is currently -3.37% below its 50-day simple moving average

RSI

50.00
GDRX 14-day relative strength index is 50.00

Volume

0.37
GDRX 30-day relative volume is 0.37

ATR

$0.25
GDRX average true range is $0.25

10-day Historical Volatility

93.17%
GDRX 10-day historical volatility is 93.17%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$792.32M
GDRX annual revenue is $792.32 million

Revenue Analysts estimate

$823.25M
GDRX annual revenue is currently -3.76% lower than the consensus analysts' forecast

Revenue 1-year change

+5.61%
GDRX annual revenue is up +5.61% year-on-year

Revenue Sector rank

78.84%
GDRX annual revenue is higher than 78.84% of companies in Healthcare sector

EPS

EPS

$0.04
GDRX annual earnings per share is $0.04

EPS Analysts estimate

$0.40
GDRX annual earnings per share is currently -90.07% lower than the consensus analysts' forecast

EPS 1-year change

+300%
GDRX annual earnings per share is up +300% year-on-year

EPS Sector rank

82.89%
GDRX annual earnings per share is higher than 82.89% of companies in Healthcare sector

Profit

Gross profit

$744.11M
GDRX annual gross profit is $744.11 million

Gross margin

93.91%
GDRX annual gross profit margin is 93.91%

Operating profit

$65.85M
GDRX annual operating income is $65.85 million

Operating margin

8.31%
GDRX annual operating profit margin is 8.31%

Net income

$16.39M
GDRX annual net profit is $16.39 million

Net margin

2.07%
GDRX annual net profit margin is 2.07%

Expenses

Total expenses

$726.48M
GDRX annual total expenses is $726.48 million

Operating expenses

$678.26M
GDRX annual total operating expenses is $678.26 million

Cost of goods sold

$48.22M
GDRX annual cost of goods sold is $48.22 million

Selling, general & administrative expenses

$484.98M
GDRX annual SGA is $484.98 million

Depreciation and amortization

$69.54M
GDRX annual depreciation & amortization is $69.54 million

Interest expense

$52.92M
GDRX annual interest expense is $52.92 million

Income tax

$15.07M
GDRX annual income tax is $15.07 million

EBIT & EBITDA

EBIT

$84.38M
GDRX annual earnings before interest & taxes is $84.38 million

EBITDA

$153.92M
GDRX annual EBITDA is $153.92 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$1.39B
GDRX annual total assets is $1.39 billion

Non current assets

$728.81M
GDRX annual long term assets is $728.81 million

Current assets

$659.25M
GDRX annual total current assets is $659.25 million

Cash and cash equivalents

$448.35M
GDRX annual cash & cash equivalents is $448.35 million

Accounts receivable

$145.93M
GDRX annual accounts receivable is $145.93 million

Inventory

-
GDRX annual inventory value is unknown

Liabilities

Total liabilities

$663.41M
GDRX annual total liabilities is $663.41 million

Long term liabilities

$539.51M
GDRX annual total long term liabilities is $539.51 million

Current liabilities

$123.90M
GDRX annual total current liabilities is $123.90 million

Accounts payable

$14.14M
GDRX annual accounts payable is $14.14 million

Debt

Total debt

$543.39M
GDRX annual total debt is $543.39 million

Total debt 1-year change

-23.58%
GDRX annual total debt is down -23.58% year-on-year

Long term debt

$532.75M
GDRX annual long term debt is $532.75 million

Short term debt

$10.64M
GDRX annual short term debt is $10.64 million

Equity & Capital

Shareholders equity

$724.66M
GDRX annual stockholders equity is $724.66 million

Book value

$724.66M
GDRX annual book value is $724.66 million

Retained earnings

-$1.44B
GDRX annual retained earnings is -$1.44 billion

Working capital

$535.35M
GDRX annual working capital is $535.35 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

$183.89M
GDRX annual cash flow from operations is $183.89 million

Cash from operations 1-year change

+32.97%
GDRX annual cash flow from operations is up +32.97% year-on-year

Cash from investing

-$70.35M
GDRX annual cash flow from investing activities is -$70.35 million

Cash from investing 1-year change

-26.15%
GDRX annual cash flow from investing activities is down -26.15% year-on-year

Cash from financing

-$337.50M
GDRX annual cash flow from financing activities is -$337.50 million

Cash from financing 1-year change

-101.62%
GDRX annual cash flow from financing activities is down -101.62% year-on-year

CAPEX

CAPEX

$70.35M
GDRX annual capital expenditures is $70.35 million

CAPEX 1-year change

+26.15%
GDRX annual capital expenditures is up +26.15% year-on-year

Free Cash Flow

Free cash flow

$113.55M
GDRX annual free cash flow is $113.55 million

Free cash flow 1-year change

+37.59%
GDRX annual free cash flow is up +37.59% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

93.91%
GDRX annual gross profit margin is 93.91%

Operating margin

8.31%
GDRX annual operating profit margin is 8.31%

Net margin

2.07%
GDRX annual net profit margin is 2.07%

ROA & ROE

ROA

1.10%
GDRX annual return on assets is 1.10%

ROE

2.21%
GDRX annual return on equity is 2.21%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

94.62
GDRX price to earnings ratio is 94.62

PE ratio Sector rank

90.2%
GDRX price to earnings ratio is higher than 90.2% of companies in Healthcare sector

PB Ratio

PB ratio

2.37
GDRX price to book ratio is 2.37

PB ratio Sector rank

67.3%
GDRX price to book ratio is higher than 67.3% of companies in Healthcare sector

PS Ratio

PS ratio

2.17
GDRX price to sales ratio is 2.17

PS ratio Sector rank

44.74%
GDRX price to sales ratio is higher than 44.74% of companies in Healthcare sector

Enterprise value

Enterprise value

$1.82B
GDRX enterprise value is $1.82 billion

Enterprise value Sector rank

81.59%
GDRX enterprise value is higher than 81.59% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

11.80
GDRX EV/EBITDA is 11.80

EV/EBITDA Sector rank

85.04%
GDRX EV/EBITDA is higher than 85.04% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

5.32
GDRX annual current ratio is 5.32

Quick ratio

-
GDRX annual quick ratio value is unknown

Leverage

Debt to equity

0.68
GDRX annual debt to equity ratio is 0.68

Interest coverage ratio

1.59
GDRX annual interest coverage ratio is 1.59

Risk & Stability

Piotroski F-Score

8
GDRX piotroski f-score is 8

Altman Z-Score

1.34
GDRX altman z-score is 1.34

Analyst ratings

Recent major analysts updates

Apr 10, 25 Truist Securities
Hold
Feb 28, 25 Wells Fargo
Overweight
Jan 10, 25 Citigroup
Buy
Jan 8, 25 Keybanc
Overweight
Dec 17, 24 Morgan Stanley
Equal-Weight
Nov 13, 24 Citigroup
Buy
Nov 11, 24 Barclays
Overweight
Aug 16, 24 RBC Capital
Outperform
Aug 9, 24 UBS
Neutral
Aug 9, 24 Citigroup
Buy

Institutional Ownership

Similar stocks

WRBY logo
Warby Parker (WRBY)
SUPN logo
Supernus Pharmaceuticals (SUPN)
NVCR logo
NovoCure Limited (NVCR)
QDEL logo
QuidelOrtho (QDEL)
KYMR logo
Kymera Therapeutics (KYMR)
JANX logo
Janux Therapeutics (JANX)
PINC logo
Premier (PINC)
Ardent Health Partners LLC (ARDT)
AGL logo
agilon health (AGL)
  • What is the ticker symbol for GoodRx Holdings?
  • Does GoodRx Holdings pay dividends?
  • What sector is GoodRx Holdings in?
  • What industry is GoodRx Holdings in?
  • What country is GoodRx Holdings based in?
  • When did GoodRx Holdings go public?
  • Is GoodRx Holdings in the S&P 500?
  • Is GoodRx Holdings in the NASDAQ 100?
  • Is GoodRx Holdings in the Dow Jones?
  • When was GoodRx Holdings's last earnings report?
  • When does GoodRx Holdings report earnings?
  • Should I buy GoodRx Holdings stock now?

What is the ticker symbol for GoodRx Holdings?

The ticker symbol for GoodRx Holdings is NASDAQ:GDRX

Does GoodRx Holdings pay dividends?

No, GoodRx Holdings does not pay dividends

What sector is GoodRx Holdings in?

GoodRx Holdings is in the Healthcare sector

What industry is GoodRx Holdings in?

GoodRx Holdings is in the Health Information Services industry

What country is GoodRx Holdings based in?

GoodRx Holdings is headquartered in United States

When did GoodRx Holdings go public?

GoodRx Holdings's initial public offering (IPO) was on September 23, 2020

Is GoodRx Holdings in the S&P 500?

No, GoodRx Holdings is not included in the S&P 500 index

Is GoodRx Holdings in the NASDAQ 100?

No, GoodRx Holdings is not included in the NASDAQ 100 index

Is GoodRx Holdings in the Dow Jones?

No, GoodRx Holdings is not included in the Dow Jones index

When was GoodRx Holdings's last earnings report?

GoodRx Holdings's most recent earnings report was on Feb 27, 2025

When does GoodRx Holdings report earnings?

The next expected earnings date for GoodRx Holdings is May 7, 2025

Should I buy GoodRx Holdings stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page